These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11995488)

  • 1. Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.
    Iwasa M; Kaito M; Ikoma J; Kobayashi Y; Tanaka Y; Higuchi K; Takeuchi K; Iwata K; Watanabe S; Adachi Y
    Hepatogastroenterology; 2002; 49(44):529-31. PubMed ID: 11995488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
    Iwasa M; Iwata K; Kaito M; Ikoma J; Yamamoto M; Takeo M; Kuroda M; Fujita N; Kobayashi Y; Adachi Y
    Nutrition; 2004 Apr; 20(4):368-71. PubMed ID: 15043853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
    Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
    Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
    Girelli CM; Mirata C; Casiraghi A
    Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.
    Hayashi H; Takikawa T; Nishimura N; Yano M; Isomura T; Sakamoto N
    Am J Gastroenterol; 1994 Jul; 89(7):986-8. PubMed ID: 8017395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
    Yano M; Hayashi H; Yoshioka K; Kohgo Y; Saito H; Niitsu Y; Kato J; Iino S; Yotsuyanagi H; Kobayashi Y; Kawamura K; Kakumu S; Kaito M; Ikoma J; Wakusawa S; Okanoue T; Sumida Y; Kimura F; Kajiwara E; Sata M; Ogata K
    J Gastroenterol; 2004 Jun; 39(6):570-4. PubMed ID: 15235875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron depletion and response to interferon in chronic hepatitis C.
    Carlo C; Daniela P; Giancarlo C
    Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
    Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
    Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron].
    Cagnoni C; Corsini F; Pancotti D; Carrara G
    Ann Ital Med Int; 2000; 15(2):132-8. PubMed ID: 10920503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
    Okanoue T; Makiyama A; Nakayama M; Sumida Y; Mitsuyoshi H; Nakajima T; Yasui K; Minami M; Itoh Y
    J Hepatol; 2005 Oct; 43(4):599-605. PubMed ID: 16024129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
    Shan Y; Lambrecht RW; Bonkovsky HL
    Clin Infect Dis; 2005 Mar; 40(6):834-41. PubMed ID: 15736017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
    Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
    Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
    Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
    Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
    J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
    Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
    Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.